A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?;Braid grave en paciente con encefalitis aguda diseminada recurrente por vacuna contra la hepatitis B. ¿A favor o en contra de la vacunación?

Revista de Neurologia

Volumn 34, Issue 4, 2002, Pages 358-362

  Cabrera Gómez, José A ^a   Echazabal Santana, N ^a   Garcia Gonzalez L F ^a   Ramos Cedeno A ^a   Rodriguez Roque M O ^a   Lopez Hernandez O ^a   Cabrera Nunez J A ^a   Gonzalez de la Nuez J E ^a   Tellez L ^a  

^a Gustavo Aldereguía Lima   (Cuba)

Author keywords

Demyelinating diseases; Hepatitis B vaccine; Multiple sclerosis; Recurrent disseminated acute encephalitis.

Indexed keywords

HEPATITIS B VACCINE; INSULIN; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE COURSE; ENCEPHALITIS; HEPATITIS B; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; MALE; MULTIPLE SCLEROSIS; VACCINATION; BRAIN; DIFFERENTIAL DIAGNOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSTVACCINAL ENCEPHALITIS; RECURRENT DISEASE;

ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; BRAIN; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; PREDNISONE; RECURRENCE; VACCINATION;

EID: 0037116713     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3404.2001217     Document Type: Article

References (15)

1. Central nervous system demyelination after recombinant hepatitis B vaccination. Report of 25 cases
2. Hepatitis B vaccine and central nervous system demyelinating diseases
3. Encephalitis after hepatitis B vaccination. Recurrent disseminated encephalitis or MS?
4. The epidemiology of multiple sclerosis. A general overview
5. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
6. Magnetic resonance imaging in the assessment of disease activity in multiple sclerosis
7. Criteria for an increased specificity of MR interpretation in elderly subjects with suspected multiple sclerosis
8. Commentary: Public perception and the safety of immunization
9. A shadow falls on hepatitis B vaccination effort
10. Assessment: Neurologic risk of immunization. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology
11. School-based hepatitis B vaccination programme and adolescent multiple sclerosis
12. Demyelination, multiple sclerosis and hepatitis B vaccination: A population-based study in United Kingdom
13. Vaccinations and the risk of relapse in multiple sclerosis
14. Demyelinating disease and hepatitis B vaccination: Survey of 735 patients seen at MS Clinic
15. Development of multiple sclerosis after hepatitis B vaccination: An immunologic case report